主动脉缩窄合并三叶式主动脉瓣不增加升主动脉瘤风险
本研究将867例主动脉缩窄(COA)患者与867例孤立性二叶式主动脉瓣(BAV)患者及867例无结构性心脏病(SHD)患者进行1:1:1匹配,并在基线及3、5、7年评估主动脉尺寸。结果显示,BAV而非COA与升主动脉尺寸增大相关;COA合并三叶式主动脉瓣(TAV)患者与无SHD患者相比,升主动脉瘤风险未增加。
要点
- BAV而非COA与升主动脉扩张相关。
- COA+TAV患者升主动脉瘤风险与无SHD者相当。
- 所有组急性主动脉并发症风险均低。
核心结论
- BAV而非COA与升主动脉尺寸增大相关,COA+TAV患者升主动脉瘤风险不高于无SHD患者。
研究设计与样本
- 研究纳入867例COA患者,与867例孤立性BAV患者和867例无SHD患者进行1:1:1匹配。
- COA组进一步分为COA+BAV亚组(n=304,35%)和COA+TAV亚组(n=563,65%)。
- 在基线及3、5、7年评估主动脉尺寸。
主要发现
- 与无SHD组相比,COA+BAV亚组主动脉根部直径更大(37 mm [Q1-Q3: 30-43 mm] vs 32 mm [Q1-Q3: 27-35 mm];P < 0.001)。
- 与无SHD组相比,COA+BAV亚组升主动脉中段直径更大(34 mm [Q1-Q3: 29-40 mm] vs 28 mm [Q1-Q3: 24-31 mm];P = 0.008)。
- 与无SHD组相比,BAV组主动脉根部直径更大(37 mm [Q1-Q3: 30-42 mm] vs 32 mm [Q1-Q3: 27-35 mm];P < 0.001)。
- 与无SHD组相比,BAV组升主动脉中段直径更大(35 mm [Q1-Q3: 30-40 mm] vs 28 mm [Q1-Q3: 24-31 mm];P < 0.001)。
- 与COA+TAV亚组相比,COA+BAV亚组和BAV组在基线及随访时主动脉根部和升主动脉中段直径更大。
临床怎么用
- 对于COA合并TAV患者,升主动脉瘤监测策略可参考无SHD人群。
- 对于COA合并BAV患者,应关注升主动脉扩张风险。
局限性
- 所有组急性主动脉并发症风险均低,可能限制对罕见事件的评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Aortic aneurysm is common in patients with coarctation of aorta (COA), but it is unclear whether the risk of aortic aneurysms is due to COA or related to the presence of other risk factors such as bicuspid aortic valve (BAV) and hypertension. OBJECTIVES: The purpose of this study was to assess the relationship among COA, BAV, and thoracic aortic aneurysms. METHODS: A total of 867 patients with COA (COA group) were matched 1:1:1 to 867 patients with isolated BAV (BAV group) and 867 patients without structural heart disease (SHD) (no-SHD group). The COA group was further subdivided into a COA+BAV subgroup (n = 304 [35%]), and COA with tricuspid aortic valve (TAV) (COA+TAV subgroup [n = 563 (65%)]). Aortic dimensions were assessed at baseline and at 3, 5, and 7 years. RESULTS: Compared with the no-SHD group, the COA+BAV subgroup had larger aortic root diameter (37 mm [Q1-Q3: 30-43 mm] vs 32 mm [Q1-Q3: 27-35 mm]; P < 0.001) and mid ascending aorta dimeter (34 mm [Q1-Q3: 29-40 mm] vs 28 mm [Q1-Q3: 24-31 mm]; P = 0.008). Similarly, the BAV group had larger aortic root diameter (37 mm [Q1-Q3: 30-42 mm] vs 32 mm [Q1-Q3: 27-35 mm]; P < 0.001), and mid ascending aorta dimeter (35 mm [Q1-Q3: 30-40 mm] vs 28 mm [Q1-Q3: 24-31 mm]; P < 0.001). Compared with the COA+TAV subgroup, the COA+BAV subgroup and BAV group were associated with larger aortic root and mid ascending aorta diameter at baseline and follow-up. The risk of acute aortic complications was low in all groups. CONCLUSIONS: These findings suggest that BAV (and not COA) was associated with ascending thoracic aorta dimensions, and that patients with COA+TAV were not at a greater risk of developing ascending aortic aneurysms as compared with patients without SHD.
引用
- Egbe AC, Miranda WR, Abozied O, et al. Coarctation of Aorta With Tricuspid Aortic Valve Is Not Associated With Ascending Aortic Aneurysm. J Am Coll Cardiol. 2024. PMID: 38508846. doi:10.1016/j.jacc.2024.01.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。